FINTEPLA is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Zogenix, Inc.. The primary component is Fenfluramine.
| Product ID | 43376-322_1b988653-f85f-410d-b340-055aa0e52772 |
| NDC | 43376-322 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FINTEPLA |
| Generic Name | Fenfluramine |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212102 |
| Labeler Name | Zogenix, Inc. |
| Substance Name | FENFLURAMINE |
| Active Ingredient Strength | 2 mg/mL |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-07-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FINTEPLA 88284913 not registered Live/Pending |
ZOGENIX INTERNATIONAL LIMITED 2019-01-31 |
![]() FINTEPLA 87687367 not registered Dead/Abandoned |
ZOGENIX INTERNATIONAL LIMITED 2017-11-16 |
![]() FINTEPLA 86949118 5443859 Live/Registered |
Zogenix International Limited 2016-03-22 |